Democratic chair: Medicare negotiating drug prices not moving before August

Democratic chair: Medicare negotiating drug prices not moving before August
© istock

A measure lawmakers have been working on for months to allow Medicare to negotiate drug prices will not move forward before Congress leaves for the August recess, said a key Democrat involved in the legislation.

“I really wanted to see that done pre-August, and I don't think that's going to be the case,” said Rep. Anna EshooAnna Georges EshooHillicon Valley: Biden calls for revoking tech legal shield | DHS chief 'fully expects' Russia to try to interfere in 2020 | Smaller companies testify against Big Tech 'monopoly power' Lawmakers call for FTC probe into top financial data aggregator Overnight Health Care: Health insurers urge Supreme Court to take ObamaCare case | Lawmakers press Trump officials to change marijuana rules | Bloomberg vows to ban flavored e-cigs if elected MORE (D-Calif.), the chairwoman of the House Energy and Commerce Health Subcommittee.

ADVERTISEMENT
Allowing Medicare to negotiate prices with drug companies is one of House Democrats’ top priorities, but the party has been trying to overcome divisions on how to structure the proposal. Progressive lawmakers are pushing Speaker Nancy PelosiNancy PelosiFormer senior Senate GOP aide says Republicans should call witnesses Democrats step up pressure over witnesses after Bolton bombshell Texas AFL-CIO endorses Cuellar's primary challenger MORE (D-Calif.) to take what they view as a stronger line against drug companies. 

House Majority Leader Steny HoyerSteny Hamilton HoyerThe Hill's Morning Report - Trump trial begins with clash over rules House revives agenda after impeachment storm House poised to hand impeachment articles to Senate MORE (D-Md.) told reporters Tuesday that there is no agreement yet on the legislation. 

“The committee's still discussing it,” Hoyer said, later adding, “They have not reached agreement on that so it's doubtful it will be next week.”

Progressive lawmakers are pushing for a mechanism that would strip drug companies of their monopolies if they refused to negotiate a reasonable price with Medicare. Pelosi’s office and key committee leaders have been discussing a different approach to have an outside arbiter step in to set the price if Medicare and the drug company cannot agree. 

“I don’t have any timetable, I just know that we're working on it,” House Energy and Commerce Committee Chairman Frank Pallone Jr.Frank Joseph PalloneOvernight Health Care — Presented by That's Medicaid — Deal on surprise medical bills faces obstacles | House GOP unveils rival drug pricing measure ahead of Pelosi vote | Justices to hear case over billions in ObamaCare payments Obstacles remain for deal on surprise medical bills This week: House impeachment inquiry hits crucial stretch MORE (D-N.J.) told reporters last week. 

Progressive groups have been anxious for Democrats to act on one of their top priorities. 

Asked how work is coming on the measure, Eshoo replied, “It's above my paygrade."